Welcome to LookChem.com Sign In|Join Free

CAS

  • or

218301-22-5

Post Buying Request

218301-22-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

218301-22-5 Usage

Chemical Properties

White Solid

Uses

Different sources of media describe the Uses of 218301-22-5 differently. You can refer to the following data:
1. 2-Fluoro-5-ForMyl-benzonitrile is used in the preparation of heterocyclic compounds as PARP inhibitors for medical use.
2. 2-Fluoro-5-formylbenzonitrile may be used in the synthesis of 3-cyano-4-fluorobenzyl bromide.

General Description

2-Fluoro-5-formylbenzonitrile is a benzonitrile derivative.

Check Digit Verification of cas no

The CAS Registry Mumber 218301-22-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,3,0 and 1 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 218301-22:
(8*2)+(7*1)+(6*8)+(5*3)+(4*0)+(3*1)+(2*2)+(1*2)=95
95 % 10 = 5
So 218301-22-5 is a valid CAS Registry Number.
InChI:InChI=1S/C8H4FNO/c9-8-2-1-6(5-11)3-7(8)4-10/h1-3,5H

218301-22-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-FLUORO-5-FORMYLBENZONITRILE

1.2 Other means of identification

Product number -
Other names 2-fluoro-5-formyl-benzonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:218301-22-5 SDS

218301-22-5Relevant articles and documents

Novel indazole derivatives, and use thereof

-

Paragraph 0112-0124, (2019/08/12)

The present invention refers to novel indazole derivatives, or pharmaceutically acceptable salts; and including DYRK1A DYRK1B active ingredient (Dual non-specificity tyrosine phosphorylation in a non-regulated kinase 1a) or a pharmaceutical composition for preventing or treating related disorders are disclosed. (by machine translation)

HETEROCYCLIC DERIVATES, PREPARATION PROCESSES AND MEDICAL USES THEREOF

-

Paragraph 0137; 0138, (2013/09/12)

Disclosed are heterocyclic derivatives, methods for making them, compositions containing the same and uses thereof. Particularly, their pharmaceutical use as inhibitors of PARP is disclosed.

NOVEL OXADIAZOLE COMPOUNDS

-

Page/Page column 176-177, (2011/06/26)

Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation o

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 218301-22-5